Approval · Notice of Compliance 15149 · 2014
GENOTROPIN (GOQUICK): Notice of Compliance 15149
Issued January 24, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15149
- Date
- January 24, 2014
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing process and new manufacturing site
- Therapeutic class
- Human growth hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GENOTROPIN (GOQUICK) | Not yet assigned | — |
| GENOTROPIN (MINIQUICK) | Not yet assigned | — |
Medicinal ingredients
- SOMATROPIN 5 MG per PEN
- SOMATROPIN 5.3 MG per PEN
- SOMATROPIN 12 MG per PEN
- SOMATROPIN 0.2 MG per SYR
- SOMATROPIN 0.4 MG per SYR
- SOMATROPIN 0.6 MG per SYR
- SOMATROPIN 0.8 MG per SYR
- SOMATROPIN 1 MG per SYR
- SOMATROPIN 1.2 MG per SYR
- SOMATROPIN 1.4 MG per SYR
- SOMATROPIN 1.6 MG per SYR
- SOMATROPIN 1.8 MG per SYR
- SOMATROPIN 2 MG per SYR